We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Plavix insurance

16 February 2004 By Hugo Dixon

Protecting Aventis if Sanofi’s profitable cardiovascular drug loses its patent would neutralise a big argument against the hostile bid. It would also be fair. Here is an innovative way of providing such insurance.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)